Tonix Pharmaceuticals (TNXP) News Today

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) rallied on July 10 after a string of positive clinical updates, including peer-reviewed data and vaccine findings, but saw a pullback on July 11 amid profit-taking.

• Positive Sentiment: Tonix Pharmaceuticals announced presentation of new TNX-801 mpox and smallpox vaccine data at the Vaccine Congress 2025, highlighting robust, durable immunity and favorable subcutaneous administration. GlobeNewswire Release
• Positive Sentiment: GuruFocus reported Tonix’s presentation of new TNX-801 mpox and smallpox vaccine data at the Vaccine Congress, underscoring strong immunogenicity and safety. GuruFocus News #1
• Positive Sentiment: GuruFocus published a follow-up report on Tonix’s TNX-801 vaccine data from the Vaccine Congress, reinforcing confidence in the live recombinant horsepox candidate. GuruFocus News #2
• Positive Sentiment: GuruFocus highlighted additional promising TNX-801 vaccine findings, bolstering the outlook for Tonix’s infectious-disease pipeline. GuruFocus News #3
• Positive Sentiment: TipRanks covered Tonix’s unveiling of promising TNX-801 vaccine findings, emphasizing the candidate’s robust protective profile in preclinical models. TipRanks Announcement
• Positive Sentiment: MSN reported that Tonix shares rose on peer-reviewed pain-therapy data alongside new mpox vaccine findings, fueling investor optimism. MSN Health Report #1
• Positive Sentiment: MSN noted shares climbed further on encouraging TNX-801 vaccine results, reflecting positive early-stage outcomes. MSN Health Report #2
• Positive Sentiment: Tonix surged roughly 10% on the release of Phase 3 data for its pain-management candidate, signaling strong efficacy potential. GuruFocus Phase 3 Data
• Positive Sentiment: MarketBeat flagged an 11.4% uptick in TNXP shares, posing the question of whether the recent rally presents a buying opportunity. MarketBeat Buy Alert
• Neutral Sentiment: July short interest data showed zero shares on loan, yielding a 0-day cover ratio based on average daily volume, suggesting minimal bearish bets.
• Negative Sentiment: MarketBeat reported a 5.8% pullback in TNXP shares on July 11, indicating profit-taking pressure after the series of positive catalysts. MarketBeat Sell Alert